Cellular Immunotherapy
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the cellular immunotherapy market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[197 Pages Report] The Cellular Immunotherapy Market size was estimated at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024, at a CAGR 25.34% to reach USD 54.60 billion by 2030.

Cellular immunotherapy is a form of treatment primarily used for cancer, where the patient's immune cells are harnessed or modified to fight the cancer more effectively. This innovative approach taps into the body's natural defense mechanisms, leveraging the immune system's ability to recognize and destroy abnormal cells. The increasing cases of global cancer cases have intensified the search for effective treatments, positioning cellular immunotherapy as a vital option. Continuous improvements in biotechnology and a deeper understanding of cancer biology have enhanced the efficacy and applicability of cellular immunotherapies. Cellular immunotherapies' complex manufacturing and personalized nature result in significant treatment expenses, limiting access for many patients. Cellular immunotherapies can have considerable side effects, requiring further research and monitoring. Cellular immunotherapies can lead to severe side effects, necessitating careful patient monitoring and management strategies. The production and delivery of cell-based therapies involve intricate processes that pose logistical challenges, impacting treatment accessibility and effectiveness. Emerging markets present untapped opportunities, fueled by increasing healthcare investments and awareness. Research into cellular immunotherapy for diseases other than cancer, such as autoimmune and infectious diseases.
Regional Insights

The cellular immunotherapy market demonstrates a dynamic international landscape with significant activity across various regions. The United States and Canada are at the forefront due to heavy research and development investments, advanced biotech industries, and supportive regulatory frameworks. European countries, including the United Kingdom, Germany, and France, benefit from collective regulatory environments encouraging cross-border research and clinical trials. The Middle East, particularly the United Arab Emirates and Saudi Arabia, heavily invests in healthcare infrastructure, while African countries such as South Africa and Nigeria are adopting advanced medical technologies. The Asia-Pacific region sees increasing demand for advanced treatments driven by chronic disease prevalence and rising incomes. China is emerging as a significant player with robust governmental support and substantial biotech investment. Japan leverages quick regulatory approvals within a highly developed healthcare system, and India is gaining traction with a large patient base and increasing healthcare investment. In Latin America, Brazil and Mexico are leading due to improving healthcare infrastructure. South Africa and ASEAN countries such as Singapore and Malaysia are drawing attention for their supportive regulatory environments and biotech investments.

The regulatory frameworks for cellular immunotherapy differ significantly across geographies, influencing how vendors develop and market their products. In the United States, the Food and Drug Administration (FDA) uses designations such as Fast Track and Breakthrough Therapy to expedite approvals, encouraging early vendor collaboration. The European Medicines Agency (EMA) in the European Union promotes a centralized process with the PRIME Scheme and Adaptive Pathways, facilitating cross-border collaborations and trials. China's National Medical Products Administration (NMPA) streamlines approvals with its Innovate First, Review Later policy, fostering global partnerships. Japan's Pharmaceuticals and Medical Devices Agency (PMDA) supports rapid commercialization through expedited review systems such as the Sakigake Designation, with vendors engaging in joint ventures and R&D collaborations. The future scope in developed countries includes advancements in personalized medicine and technological integration, though challenges such as complex regulations, high R&D costs, and supply chain management persist. Emerging countries such as India, Brazil, and South Africa offer vast potential due to large patient populations and growing healthcare investments.

Cellular Immunotherapy Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Cellular Immunotherapy Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Prevalence of cancer and advanced cell based therapies
    • Favorable government initiatives for cellular therapies R&D
    • Increasing prevalence for tumor-infiltrating lymphocyte (TIL) therapy and engineered T cell receptor (TCR) therapy
  • Market Restraints
    • High initial costs of devices and therapies
  • Market Opportunities
    • Technological advancements and new products for cellular immunotherapy
    • Increasing approvals of different cell-based immunotherapy drugs
  • Market Challenges
    • Product recalls and stringent regulatory approvals
Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Cellular Immunotherapy Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Cellular Immunotherapy Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Cellular Immunotherapy Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Cellular Immunotherapy Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Cellular Immunotherapy Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Cellular Immunotherapy Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Cellular Immunotherapy Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Cellular Immunotherapy Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Cellular Immunotherapy Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Cellular Immunotherapy Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

Before using the Cellular Immunotherapy Market Research Report by 360iResearch, we faced significant challenges in getting approvals for our cell-based immunotherapy drugs. This detailed report provided invaluable insights and actionable strategies that helped us navigate the complex regulatory environment. Thanks to the report, we identified key areas for improvement, leading to a smoother approval process. Our successful approval rates have increased, and the report's detailed market analysis has been pivotal in shaping our strategic decisions. Our overall satisfaction with how this report has positively impacted our operations is very high.
GlaxoSmithKline PLC
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cellular Immunotherapy Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cellular Immunotherapy Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cellular Immunotherapy Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

As a satisfied client of the Cellular Immunotherapy Market Research Report by 360iResearch, we faced significant challenges in understanding and navigating the emerging landscape of cellular therapies R&D. The comprehensive and detailed findings in the report, particularly regarding favorable government initiatives, provided us with valuable insights and actionable strategies. Implementing the recommended strategies, we were able to streamline our research and development efforts, resulting in accelerated project timelines and improved compliance with regulatory standards. The report has positively impacted our operations, making it an indispensable resource for our strategic planning and execution.
Immatics N.V.
Key Company Profiles

The report delves into recent significant developments in the Cellular Immunotherapy Market, highlighting leading vendors and their innovative profiles. These include GlaxoSmithKline PLC, Immatics N.V., Eli Lilly and Company, F. Hoffmann-La Roche AG, Pfizer Inc., JW Therapeutics (Shanghai) Co., Ltd., Lonza Group Ltd., Adicet Bio, Inc., Bio-Rad Laboratories, Inc., Iovance Biotherapeutics, Inc., Novartis AG, Atara Biotherapeutics, Inc., Dendreon Pharmaceuticals LLC, Corning Incorporated, Glycostem Therapeutics B.V., Bristol-Myers Squibb Company, Adaptimmune Therapeutics PLC, Merck KGaA, Tessa Therapeutics Ltd., Celyad Oncology SA, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., AstraZeneca PLC, Apac Biotech Private Limited, and Inovio Pharmaceuticals, Inc..

Cellular Immunotherapy Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Cellular Immunotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • CAR T-Cell Therapy
    • Dendritic Cell Therapy
    • NK Cell Therapy
    • Tumor-Infiltrating Lymphocytes Therapy
  • Indication
    • B-Cell Malignancies
    • Liver Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
  • Technology Type
    • Cytokines & Immunomodulators
    • Monoclonal Antibodies
  • End-Use
    • Cancer Institutes
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

As a leading company seeking to innovate in the field of cellular immunotherapy, we faced numerous challenges in understanding the market dynamics and growth opportunities for TIL and TCR therapies. The Cellular Immunotherapy Market Research Report by 360iResearch provided us with invaluable insights and actionable strategies that have been crucial in guiding our strategic decisions. The detailed analysis and forward-looking perspectives enabled us to identify key trends, potential risks, and growth prospects effectively. For instance, the report highlighted emerging markets that we had not previously considered, allowing us to expand our reach and develop targeted strategies for those areas. The comprehensive data and rigorous research methodology gave us confidence in aligning our resources and efforts with market demands. Overall, the report has significantly positively impacted our operations, supporting our mission to bring innovative therapies to patients more efficiently and effectively. Our satisfaction with 360iResearch's report is immense, and we highly recommend their expertise to any organization looking to excel in the competitive landscape of cellular immunotherapy.
Eli Lilly and Company
This research report offers invaluable insights into various crucial aspects of the Cellular Immunotherapy Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Cellular Immunotherapy Market, by Type
  7. Cellular Immunotherapy Market, by Indication
  8. Cellular Immunotherapy Market, by Technology Type
  9. Cellular Immunotherapy Market, by End-Use
  10. Americas Cellular Immunotherapy Market
  11. Asia-Pacific Cellular Immunotherapy Market
  12. Europe, Middle East & Africa Cellular Immunotherapy Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 376]
  17. List of Companies Mentioned [Total: 25]
Frequently Asked Questions
  1. How big is the Cellular Immunotherapy Market?
    Ans. The Global Cellular Immunotherapy Market size was estimated at USD 11.23 billion in 2023 and expected to reach USD 14.02 billion in 2024.
  2. What is the Cellular Immunotherapy Market growth?
    Ans. The Global Cellular Immunotherapy Market to grow USD 54.60 billion by 2030, at a CAGR of 25.34%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.